The unwell patient with advanced chronic liver disease: when to use each score?
Abstract Background Prognostication in chronic liver disease and the implementation of appropriate scoring systems is difficult given the variety of clinical manifestations. It is important to understand the limitations of each scoring system as well as the context and patient group from which it wa...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | BMC Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12916-025-04185-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849235100682682368 |
|---|---|
| author | Oliver Moore Wai-See Ma Scott Read Jacob George Golo Ahlenstiel |
| author_facet | Oliver Moore Wai-See Ma Scott Read Jacob George Golo Ahlenstiel |
| author_sort | Oliver Moore |
| collection | DOAJ |
| description | Abstract Background Prognostication in chronic liver disease and the implementation of appropriate scoring systems is difficult given the variety of clinical manifestations. It is important to understand the limitations of each scoring system as well as the context and patient group from which it was developed to allow appropriate application. This review seeks to explore the optimal clinical uses of different predictive scores developed for compensated and decompensated chronic liver disease, acute on chronic liver failure, and hepatocellular carcinoma. We will also review future areas of research for each score and current gaps in the literature. Main body The Child–Pugh score is the pre-eminent prediction score for liver disease that was developed through empiric selection of relevant variables. It is useful for selection of patients for surgical resection of hepatocellular carcinoma but is inferior to other scores for other clinically relevant endpoints such as survival in acute decompensations. The Model for End-Stage Liver Disease (MELD) score and subsequent variants (MELD-Na, MELD 3.0) were developed to predict mortality following elective transjugular intrahepatic portosystemic shunt (TIPS) insertion. An alternative is the Frieberg Index of Post-TIPS Survival (FIPS) score, which has been externally validated for TIPS populations. Organ allocation for liver transplantation is also currently prioritised using the MELD score, with the MELD 3.0 reducing waitlist gender discrepancies. The Chronic Liver Failure Consortium (CLIF-C) acute decompensation (AD) and acute-on-chronic liver failure (ACLF) scores are used for predicting mortality in cirrhotic patients with acute decompensation of liver disease and acute-on-chronic liver failure, respectively. Both scores were developed from retrospective analyses of an observational European cohort with external validation. Understanding of ACLF presentation of advanced liver disease remains in the preliminary stages. Improving collective understanding is important to optimise prognostication. The albumin-bilirubin score is a non-invasive predictor of survival in patients with hepatocellular carcinoma. Incorporating artificial intelligence to personalise predictive algorithms may provide the most effective prognostication for all clinical phenotypes. Conclusion We summarised key prognostic scores used in advanced liver disease and make recommendations for the optimal uses. Nuances in the development and implementation of each are discussed to help guide effective use. |
| format | Article |
| id | doaj-art-8f7b9b2cd656497c8454ecbc54578838 |
| institution | Kabale University |
| issn | 1741-7015 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Medicine |
| spelling | doaj-art-8f7b9b2cd656497c8454ecbc545788382025-08-20T04:02:55ZengBMCBMC Medicine1741-70152025-07-0123111410.1186/s12916-025-04185-wThe unwell patient with advanced chronic liver disease: when to use each score?Oliver Moore0Wai-See Ma1Scott Read2Jacob George3Golo Ahlenstiel4Blacktown Clinical School, School of Medicine, Western Sydney UniversityBlacktown Clinical School, School of Medicine, Western Sydney UniversityBlacktown Clinical School, School of Medicine, Western Sydney UniversityStorr Liver Centre, The Westmead Institute for Medical Research, University of SydneyBlacktown Clinical School, School of Medicine, Western Sydney UniversityAbstract Background Prognostication in chronic liver disease and the implementation of appropriate scoring systems is difficult given the variety of clinical manifestations. It is important to understand the limitations of each scoring system as well as the context and patient group from which it was developed to allow appropriate application. This review seeks to explore the optimal clinical uses of different predictive scores developed for compensated and decompensated chronic liver disease, acute on chronic liver failure, and hepatocellular carcinoma. We will also review future areas of research for each score and current gaps in the literature. Main body The Child–Pugh score is the pre-eminent prediction score for liver disease that was developed through empiric selection of relevant variables. It is useful for selection of patients for surgical resection of hepatocellular carcinoma but is inferior to other scores for other clinically relevant endpoints such as survival in acute decompensations. The Model for End-Stage Liver Disease (MELD) score and subsequent variants (MELD-Na, MELD 3.0) were developed to predict mortality following elective transjugular intrahepatic portosystemic shunt (TIPS) insertion. An alternative is the Frieberg Index of Post-TIPS Survival (FIPS) score, which has been externally validated for TIPS populations. Organ allocation for liver transplantation is also currently prioritised using the MELD score, with the MELD 3.0 reducing waitlist gender discrepancies. The Chronic Liver Failure Consortium (CLIF-C) acute decompensation (AD) and acute-on-chronic liver failure (ACLF) scores are used for predicting mortality in cirrhotic patients with acute decompensation of liver disease and acute-on-chronic liver failure, respectively. Both scores were developed from retrospective analyses of an observational European cohort with external validation. Understanding of ACLF presentation of advanced liver disease remains in the preliminary stages. Improving collective understanding is important to optimise prognostication. The albumin-bilirubin score is a non-invasive predictor of survival in patients with hepatocellular carcinoma. Incorporating artificial intelligence to personalise predictive algorithms may provide the most effective prognostication for all clinical phenotypes. Conclusion We summarised key prognostic scores used in advanced liver disease and make recommendations for the optimal uses. Nuances in the development and implementation of each are discussed to help guide effective use.https://doi.org/10.1186/s12916-025-04185-wLiverCirrhosisChild–PughMELDHepatocellular carcinomaACLF |
| spellingShingle | Oliver Moore Wai-See Ma Scott Read Jacob George Golo Ahlenstiel The unwell patient with advanced chronic liver disease: when to use each score? BMC Medicine Liver Cirrhosis Child–Pugh MELD Hepatocellular carcinoma ACLF |
| title | The unwell patient with advanced chronic liver disease: when to use each score? |
| title_full | The unwell patient with advanced chronic liver disease: when to use each score? |
| title_fullStr | The unwell patient with advanced chronic liver disease: when to use each score? |
| title_full_unstemmed | The unwell patient with advanced chronic liver disease: when to use each score? |
| title_short | The unwell patient with advanced chronic liver disease: when to use each score? |
| title_sort | unwell patient with advanced chronic liver disease when to use each score |
| topic | Liver Cirrhosis Child–Pugh MELD Hepatocellular carcinoma ACLF |
| url | https://doi.org/10.1186/s12916-025-04185-w |
| work_keys_str_mv | AT olivermoore theunwellpatientwithadvancedchronicliverdiseasewhentouseeachscore AT waiseema theunwellpatientwithadvancedchronicliverdiseasewhentouseeachscore AT scottread theunwellpatientwithadvancedchronicliverdiseasewhentouseeachscore AT jacobgeorge theunwellpatientwithadvancedchronicliverdiseasewhentouseeachscore AT goloahlenstiel theunwellpatientwithadvancedchronicliverdiseasewhentouseeachscore AT olivermoore unwellpatientwithadvancedchronicliverdiseasewhentouseeachscore AT waiseema unwellpatientwithadvancedchronicliverdiseasewhentouseeachscore AT scottread unwellpatientwithadvancedchronicliverdiseasewhentouseeachscore AT jacobgeorge unwellpatientwithadvancedchronicliverdiseasewhentouseeachscore AT goloahlenstiel unwellpatientwithadvancedchronicliverdiseasewhentouseeachscore |